Treatment of hypertension in patients with comorbidities: Results from the study of hypertensive prescribing practices (SHyPP)

American Journal of Hypertension

Volumn 12, Issue 4 I, 1999, Pages 333-340

  Mehta, Shilpa S ^a   Wilcox, Christopher S ^a   Schulman, Kevin A ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Comorbidities; Hypertension; Primary care

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; COMORBIDITY; DIABETES MELLITUS; DRUG INDICATION; DRUG UTILIZATION; FEMALE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DATA COLLECTION; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIURETICS; DRUG INTERACTIONS; DRUG UTILIZATION; FEMALE; GUIDELINE ADHERENCE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG; RISK FACTORS;

EID: 0032899528     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00270-2     Document Type: Article

References (28)

1. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: The Fifth Report of the Joint National Committee on the Detection, Evaluation and Treatment of High Blood Pressure (JNC-V). Arch Intern Med 1993;153:154-183.
2. Whelton PK: Epidemiology of hypertension. Lancet 1994;334:101-106.
3. MacMahon S, Peto R, Cutler J, et al: Blood pressure, stroke and coronary heart disease, part I: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774.
4. Fiebach NH, Hebert PR, Stampfer MJ, et al: A prospective study of high blood pressure and cardiovascular disease in women. Am J Epidemiol 1989;130:646-654.
5. Whelton PK, Perneger TV, Klag MJ, Brancati FL: Epidemiology and prevention of blood pressure-related renal disease. J Hypertens 1992;10(suppl 7):S77-S84.
6. Stamler J, Stamler R, Neaton JD: Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med 1993;153:598-615.
7. Insua JT, Sacks HS, Lau T, et al: Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern Med 1994;121:355-362.
8. Schulman KA, Mehta SS, Gersh BJ, et al: Study of hypertensive prescribing practices: a national survey of primary care physicians (abst). J Gen Intern Med 1998;13:42.
9. Kaplan NM, Gifford RW: Choice of initial therapy for hypertension. JAMA 1996;275:1577-1580.
10. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC-VI). Arch Intern Med 1997;157:2413-2446.
11. Garg R, Yusuf S: Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450-1456.
12. Cooper ME: Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients. J Hypertens 1996;14(suppl 6):S11-S14.
13. Kasiske BL, Kalil RS, Ma JZ, et al: Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 1993;118:129-138.
14. Bohlen L, deCourten M, Weidmann P: Comparative study of the effect of ACE inhibitors and other antihypertensive agents on proteinuria in diabetic patients. Am J Hypertens 1994;7:84S-92S.
15. Bennett PH, Haffner S, Kasiske BL, et al: Diabetic disease recommendations: screening and management of microalbuminuria in patients with diabetes. Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 1995;25:107-112.
16. Yusuf S, Peto R, Lewis J, et al: Beta blockade during and after myocardial infarction: an overview of the randomized clinical trials. Prog Cardiovasc Dis 1985;27:335-371.
17. Teo KK, Yusuf S, Furberg CD: Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 1993;270:1589-1595.
18. Kendall MJ: Clinical relevance of pharmacokinetic differences between beta blockers. Am J Cardiol 1997;80:15J-19J.
19. Soriano JB, Hoes AW, Meem L, Grobbee DE: Increased survival with beta-blockers: importance of ancillary properties. Prog Cardiovasc Dis 1997;39:445-456.
20. Grimm RH, Flack JM, Grandits GA, et al: Long-term effects on plasma lipids of diet and drugs to treat hypertension. JAMA 1996;275:1549-1556.
21. Itskovitz HD: Alpha-1 blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings. Clin Ther 1994;16:490-504.
22. Kasiske BL, Ma JZ, Kalil RS, Louis TA: Effects of antihypertensive therapy on serum lipids. Ann Intern Med 1995;122:133-141.
23. Cohn JN, Archibald DG, Ziesche S, et al: Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a veterans administration cooperative study. N Engl J Med 1986;314:1547-1552.
24. Cohn JN, Archibald DG, Francis GS, et al: Veterans administration cooperative study on vasodilator therapy of heart failure: the influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. Circulation 1987;75:IV49-IV54.
25. Murdock CJ, Hickey GM, Hockings BE, et al: Effect of alpha 1-adrenoceptor blockade on ventricular ectopic beats in acute myocardial infarction. Int J Cardiol 1990;26:45-48.
26. Siegel D, Lopez J: Trends in antihypertensive drug use in the United States: do the JNC-V recommendations affect prescribing? JAMA 1997;278:1745-1748.
27. Weber MA, Laragh JH: Hypertension: steps forward and steps backward: the joint national committee fifth report. Arch Intern Med 1993;153:149-152.
28. Wilkes MS, Doblin BH, Shapiro MF: Pharmaceutical advertisements in leading medical journals: experts' assessments. Ann Intern Med 1992;116:912-919.